XCUR
Exicure, Inc.
Price Chart
Latest Quote
$2.92
-0.04 (-1.35%)
Current Price
| Previous Close | $2.96 |
| Open | $3.00 |
| Day High | $3.09 |
| Day Low | $2.79 |
| Volume | 16,964 |
Stock Information
| Shares Outstanding | 6.37M |
| Total Debt | $22K |
| Cash Equivalents | $2.60M |
| Net Income | $-9.78M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $18.61M |
| EPS (TTM) | $-1.57 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $16.03M |
| Income | $-9.78M |
| Book/sh | $0.62 |
| Cash/sh | $0.41 |
| Employees | 8 |
Financial Ratios
| Quick Ratio | 0.60 |
| Current Ratio | 0.79 |
| Debt/Eq | 1.05 |
Returns & Margins
| ROA | -32.51% |
| ROE | -145.16% |
Ownership
| Insider Ownership | 35.38% |
| Institutional Ownership | 2.70% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -3.79 |
| P/B | 4.74 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $3.04 |
| SMA50 | $3.49 |
| SMA200 | $4.41 |
| RSI | 51.93 |
| ATR | 0.2916 |
| Shares Float | 3.38M |
| Short Float | 1.06% |
| Short Ratio | 1.93 |
| Volatility | 3.54 |
| Rel Volume | 1.20 |
Performance History
| Week | -8.46% |
| Month | -13.86% |
| Quarter | -29.64% |
| 6 Months | -47.48% |
| YTD | -47.67% |
| Year | -71.23% |
| 3 Years | -33.71% |
| 5 Years | -98.83% |
| 10 Years | -99.37% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $2.92 | 17,300 |
| 2026-06-04 | $2.96 | 22,300 |
| 2026-06-03 | $3.16 | 2,700 |
| 2026-06-02 | $3.11 | 19,900 |
| 2026-06-01 | $3.33 | 18,100 |
| 2026-05-29 | $3.19 | 15,200 |
| 2026-05-28 | $2.97 | 12,900 |
| 2026-05-27 | $2.79 | 16,400 |
| 2026-05-26 | $2.67 | 6,300 |
| 2026-05-22 | $2.81 | 15,400 |
| 2026-05-21 | $2.76 | 12,600 |
| 2026-05-20 | $2.99 | 14,000 |
| 2026-05-19 | $2.89 | 14,000 |
| 2026-05-18 | $3.06 | 24,000 |
| 2026-05-15 | $2.84 | 33,100 |
| 2026-05-14 | $3.18 | 5,100 |
| 2026-05-13 | $3.14 | 11,500 |
| 2026-05-12 | $3.24 | 8,400 |
| 2026-05-11 | $3.38 | 9,700 |
| 2026-05-08 | $3.37 | 9,900 |
| 2026-05-07 | $3.35 | 6,100 |
| 2026-05-06 | $3.39 | 11,000 |
About Exicure, Inc.
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
đ° Latest News
No news articles available at the moment. Check back later for updates on XCUR.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $500,000 | $0 | $28,826,000 |
| Operating Revenue | $0 | $500,000 | $0 | $28,826,000 |
| Expenses | ||||
| Interest Expense | $1,000 | $18,000 | $0 | $595,000 |
| Total Expenses | $10,117,000 | $5,449,000 | $13,138,000 | $30,657,000 |
| Other Income Expense | $4,509,000 | $-4,734,000 | $-3,808,000 | $38,000 |
| Other Non Operating Income Expenses | $-275,000 | $2,137,000 | $-2,000 | $-40,000 |
| Net Non Operating Interest Income Expense | $28,000 | $-10,000 | $32,000 | $-580,000 |
| Interest Expense Non Operating | $1,000 | $18,000 | $0 | $595,000 |
| Operating Expense | $10,117,000 | $5,449,000 | $13,138,000 | $30,657,000 |
| General And Administrative Expense | $6,831,000 | $5,449,000 | $11,715,000 | $10,890,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-4,946,000 | $-9,701,000 | $-16,914,000 | $-2,582,000 |
| Net Interest Income | $28,000 | $-10,000 | $32,000 | $-580,000 |
| Interest Income | $29,000 | $8,000 | $32,000 | $15,000 |
| Normalized Income | $-9,184,624 | $-4,272,910 | $-13,108,000 | $-2,643,620 |
| Net Income From Continuing And Discontinued Operation | $-4,946,000 | $-9,701,000 | $-16,914,000 | $-2,582,000 |
| Total Operating Income As Reported | $-4,233,000 | $-12,232,000 | $-14,996,000 | $-1,831,000 |
| Net Income Common Stockholders | $-4,946,000 | $-9,701,000 | $-16,914,000 | $-2,582,000 |
| Net Income | $-4,946,000 | $-9,701,000 | $-16,914,000 | $-2,582,000 |
| Net Income Including Noncontrolling Interests | $-4,946,000 | $-9,701,000 | $-16,914,000 | $-2,582,000 |
| Net Income Continuous Operations | $-4,946,000 | $-9,701,000 | $-16,914,000 | $-2,582,000 |
| Pretax Income | $-5,580,000 | $-9,693,000 | $-16,914,000 | $-2,373,000 |
| Special Income Charges | $4,677,000 | $-6,876,000 | $-1,858,000 | $0 |
| Interest Income Non Operating | $29,000 | $8,000 | $32,000 | $15,000 |
| Operating Income | $-10,117,000 | $-4,949,000 | $-13,138,000 | $-1,831,000 |
| Per Share | ||||
| Diluted EPS | $-0.79 | $-4.75 | $-10.55 | $-2.80 |
| Basic EPS | $-0.79 | $-4.75 | $-10.55 | $-2.80 |
| Other | ||||
| Tax Effect Of Unusual Items | $545,376 | $-1,442,910 | $0 | $16,380 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-9,903,000 | $-1,980,000 | $-11,733,000 | $0 |
| Total Unusual Items | $4,784,000 | $-6,871,000 | $-3,806,000 | $78,000 |
| Total Unusual Items Excluding Goodwill | $4,784,000 | $-6,871,000 | $-3,806,000 | $78,000 |
| Reconciled Depreciation | $460,000 | $824,000 | $1,375,000 | $1,856,000 |
| EBITDA (Bullshit earnings) | $-5,119,000 | $-8,851,000 | $-15,539,000 | $78,000 |
| EBIT | $-5,579,000 | $-9,675,000 | $-16,914,000 | $-1,778,000 |
| Diluted Average Shares | $6,297,094 | $2,043,278 | $1,602,790 | $923,894 |
| Basic Average Shares | $6,297,094 | $2,043,278 | $1,602,790 | $923,894 |
| Diluted NI Availto Com Stockholders | $-4,946,000 | $-9,701,000 | $-16,914,000 | $-2,582,000 |
| Tax Provision | $-634,000 | $8,000 | $0 | $209,000 |
| Gain On Sale Of Ppe | $-90,000 | $0 | $-920,000 | $0 |
| Other Special Charges | $-6,320,000 | $1,155,000 | $938,000 | - |
| Impairment Of Capital Assets | $0 | $5,721,000 | $0 | - |
| Restructuring And Mergern Acquisition | $1,553,000 | $0 | - | - |
| Gain On Sale Of Security | $107,000 | $5,000 | $-1,948,000 | $78,000 |
| Research And Development | $3,286,000 | $0 | $1,423,000 | $19,767,000 |
| Selling General And Administration | $6,831,000 | $5,449,000 | $11,715,000 | $10,890,000 |
| Other Gand A | $6,831,000 | $5,449,000 | $11,715,000 | $10,890,000 |
Fetched: 2026-06-01
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-4,257,000 | $6,772,000 | $3,031,000 | $14,922,000 |
| Total Assets | $14,041,000 | $15,056,000 | $11,580,000 | $23,328,000 |
| Total Non Current Assets | $9,417,000 | $1,383,000 | $9,556,000 | $13,277,000 |
| Non Current Prepaid Assets | $928,000 | $1,357,000 | $1,785,000 | $2,252,000 |
| Goodwill And Other Intangible Assets | $8,183,000 | $0 | - | - |
| Other Intangible Assets | $3,784,000 | - | - | - |
| Current Assets | $4,624,000 | $13,673,000 | $2,024,000 | $10,051,000 |
| Other Current Assets | $234,000 | $32,000 | $24,000 | $519,000 |
| Prepaid Assets | $586,000 | $575,000 | $934,000 | $844,000 |
| Receivables | $58,000 | $558,000 | $250,000 | $111,000 |
| Other Receivables | $58,000 | $558,000 | $250,000 | $111,000 |
| Cash Cash Equivalents And Short Term Investments | $3,746,000 | $12,508,000 | $816,000 | $8,577,000 |
| Cash And Cash Equivalents | $3,746,000 | $12,508,000 | $816,000 | $8,577,000 |
| Other Non Current Assets | - | - | $1,200,000 | $1,238,000 |
| Accounts Receivable | - | - | - | - |
| Debt | ||||
| Total Debt | $176,000 | $5,935,000 | $6,665,000 | $7,306,000 |
| Long Term Debt And Capital Lease Obligation | $0 | $5,213,000 | $6,039,000 | $6,767,000 |
| Current Debt And Capital Lease Obligation | $176,000 | $722,000 | $626,000 | $539,000 |
| Current Debt | - | - | - | - |
| Other Current Borrowings | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $10,115,000 | $8,284,000 | $8,549,000 | $8,406,000 |
| Total Non Current Liabilities Net Minority Interest | $6,227,000 | $5,213,000 | $6,039,000 | $6,767,000 |
| Other Non Current Liabilities | $5,804,000 | - | - | - |
| Non Current Deferred Liabilities | $423,000 | $0 | - | $0 |
| Non Current Deferred Taxes Liabilities | $423,000 | $0 | - | - |
| Current Liabilities | $3,888,000 | $3,071,000 | $2,510,000 | $1,639,000 |
| Payables And Accrued Expenses | $3,712,000 | $2,349,000 | $1,884,000 | $1,100,000 |
| Payables | $1,690,000 | $1,031,000 | $1,631,000 | $361,000 |
| Accounts Payable | $1,690,000 | $1,031,000 | $1,631,000 | $361,000 |
| Current Deferred Liabilities | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $3,926,000 | $6,772,000 | $3,031,000 | $14,922,000 |
| Total Equity Gross Minority Interest | $3,926,000 | $6,772,000 | $3,031,000 | $14,922,000 |
| Stockholders Equity | $3,926,000 | $6,772,000 | $3,031,000 | $14,922,000 |
| Gains Losses Not Affecting Retained Earnings | $-2,000 | $0 | $0 | $0 |
| Other Equity Adjustments | $-2,000 | - | - | - |
| Retained Earnings | $-204,210,000 | $-199,264,000 | $-189,563,000 | $-172,649,000 |
| Other | ||||
| Ordinary Shares Number | $6,373,893 | $6,026,841 | $1,730,150 | $993,180 |
| Share Issued | $6,373,893 | $6,026,841 | $1,730,150 | $993,180 |
| Tangible Book Value | $-4,257,000 | $6,772,000 | $3,031,000 | $14,922,000 |
| Invested Capital | $3,926,000 | $6,772,000 | $3,031,000 | $14,922,000 |
| Working Capital | $736,000 | $10,602,000 | $-486,000 | $8,412,000 |
| Capital Lease Obligations | $176,000 | $5,935,000 | $6,665,000 | $7,306,000 |
| Total Capitalization | $3,926,000 | $6,772,000 | $3,031,000 | $14,922,000 |
| Additional Paid In Capital | $208,137,000 | $206,035,000 | $192,594,000 | $187,571,000 |
| Capital Stock | $1,000 | $1,000 | $0 | $0 |
| Common Stock | $1,000 | $1,000 | $0 | $0 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $0 | $5,213,000 | $6,039,000 | $6,767,000 |
| Current Capital Lease Obligation | $176,000 | $722,000 | $626,000 | $539,000 |
| Current Accrued Expenses | $2,022,000 | $1,318,000 | $253,000 | $739,000 |
| Goodwill | $4,399,000 | $0 | - | - |
| Net PPE | $306,000 | $26,000 | $6,571,000 | $9,787,000 |
| Accumulated Depreciation | $-195,000 | $-253,000 | $-225,000 | $-3,650,000 |
| Gross PPE | $501,000 | $279,000 | $6,796,000 | $13,437,000 |
| Leases | $39,000 | $0 | - | - |
| Other Properties | $405,000 | $246,000 | $6,763,000 | $13,344,000 |
| Machinery Furniture Equipment | $57,000 | $33,000 | $33,000 | $93,000 |
| Properties | $0 | $0 | - | - |
| Non Current Deferred Revenue | - | - | - | $0 |
| Current Deferred Revenue | - | - | - | $0 |
| Construction In Progress | - | - | - | $0 |
| Other Short Term Investments | - | - | - | $0 |
Fetched: 2026-06-01
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-8,556,000 | $-2,910,000 | $-10,357,000 | $-35,668,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-8,555,000 | $-2,910,000 | $-10,357,000 | $-35,658,000 |
| Cash Flow From Continuing Operating Activities | $-8,555,000 | $-2,910,000 | $-10,357,000 | $-35,658,000 |
| Operating Gains Losses | $188,000 | - | $920,000 | - |
| Investing Activities | ||||
| Capital Expenditure | $-1,000 | - | - | $-10,000 |
| Investing Cash Flow | $-1,807,000 | $0 | $-1,078,000 | $4,696,000 |
| Cash Flow From Continuing Investing Activities | $-1,807,000 | $0 | $-1,078,000 | $4,696,000 |
| Capital Expenditure Reported | $-1,000 | $0 | $0 | $-10,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $1,600,000 | $12,402,000 | $5,440,000 | $5,040,000 |
| Financing Cash Flow | $1,600,000 | $13,402,000 | $3,674,000 | $-3,105,000 |
| Cash Flow From Continuing Financing Activities | $1,600,000 | $13,402,000 | $3,674,000 | $-3,105,000 |
| Net Common Stock Issuance | $1,600,000 | $12,402,000 | $5,440,000 | $5,040,000 |
| Common Stock Issuance | $1,600,000 | $12,402,000 | $5,440,000 | $5,040,000 |
| Net Other Financing Charges | - | - | $-966,000 | $-664,000 |
| Other | ||||
| Issuance Of Debt | $0 | $1,000,000 | $0 | - |
| End Cash Position | $3,746,000 | $12,508,000 | $2,016,000 | $9,777,000 |
| Beginning Cash Position | $12,508,000 | $2,016,000 | $9,777,000 | $43,844,000 |
| Changes In Cash | $-8,762,000 | $10,492,000 | $-7,761,000 | $-34,067,000 |
| Net Issuance Payments Of Debt | $0 | $1,000,000 | $0 | $-7,500,000 |
| Net Short Term Debt Issuance | $0 | $1,000,000 | $0 | - |
| Short Term Debt Issuance | $0 | $1,000,000 | $0 | - |
| Net Business Purchase And Sale | $-1,848,000 | $0 | - | - |
| Sale Of Business | $474,000 | $0 | - | - |
| Purchase Of Business | $-2,322,000 | $0 | - | - |
| Net PPE Purchase And Sale | $42,000 | $0 | $922,000 | $205,000 |
| Sale Of PPE | $42,000 | $0 | $922,000 | $205,000 |
| Change In Working Capital | $1,142,000 | $631,000 | $914,000 | $-36,815,000 |
| Change In Other Current Liabilities | $0 | $-827,000 | $-728,000 | $-637,000 |
| Change In Other Current Assets | $198,000 | $0 | $38,000 | $-2,165,000 |
| Change In Payables And Accrued Expense | $-437,000 | $987,000 | $871,000 | $-8,238,000 |
| Change In Accrued Expense | $-614,000 | $1,180,000 | $-399,000 | $-5,186,000 |
| Change In Payable | $177,000 | $-193,000 | $1,270,000 | $-3,052,000 |
| Change In Account Payable | $177,000 | $-193,000 | $1,270,000 | $-3,052,000 |
| Change In Prepaid Assets | $39,000 | $977,000 | $733,000 | $3,051,000 |
| Change In Receivables | $1,342,000 | $-506,000 | $0 | $0 |
| Changes In Account Receivables | $1,342,000 | $-506,000 | $0 | $0 |
| Other Non Cash Items | $-4,767,000 | $-407,000 | - | $516,000 |
| Stock Based Compensation | $2,000 | $22,000 | $1,348,000 | $1,369,000 |
| Asset Impairment Charge | $0 | $5,721,000 | $0 | - |
| Deferred Tax | $-634,000 | $0 | - | - |
| Deferred Income Tax | $-634,000 | $0 | - | - |
| Depreciation Amortization Depletion | $460,000 | $824,000 | $1,375,000 | $1,856,000 |
| Depreciation And Amortization | $460,000 | $824,000 | $1,375,000 | $1,856,000 |
| Depreciation | $460,000 | $824,000 | $1,375,000 | $1,856,000 |
| Gain Loss On Sale Of PPE | $90,000 | $0 | $920,000 | $0 |
| Gain Loss On Sale Of Business | $98,000 | $0 | - | - |
| Net Income From Continuing Operations | $-4,946,000 | $-9,701,000 | $-16,914,000 | $-2,582,000 |
| Proceeds From Stock Option Exercised | - | $0 | $-800,000 | $19,000 |
| Net Investment Purchase And Sale | - | $0 | $-2,000,000 | $4,501,000 |
| Purchase Of Investment | - | $0 | $-2,000,000 | $-1,499,000 |
| Unrealized Gain Loss On Investment Securities | - | $0 | $2,000,000 | $0 |
| Repayment Of Debt | - | - | $0 | $-7,500,000 |
| Net Long Term Debt Issuance | - | - | $0 | $-7,500,000 |
| Long Term Debt Payments | - | - | $0 | $-7,500,000 |
| Sale Of Investment | - | - | $0 | $6,000,000 |
| Amortization Of Securities | - | - | $0 | $-2,000 |
| Change In Other Working Capital | - | - | - | $-28,826,000 |
| Long Term Debt Issuance | - | - | - | - |
| Gain Loss On Investment Securities | - | - | - | - |
Fetched: 2026-06-01